RNF185 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.377020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.585200E-01
Normal-vs-Stage2
1.365200E-01
Normal-vs-Stage3
2.015000E-01
Normal-vs-Stage4
1.656990E-01
Stage1-vs-Stage2
3.568000E-01
Stage1-vs-Stage3
2.798200E-01
Stage1-vs-Stage4
7.752200E-01
Stage2-vs-Stage3
5.959000E-01
Stage2-vs-Stage4
5.717400E-01
Stage3-vs-Stage4
4.209600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.313850E-01
Normal-vs-AfricanAmerican
5.539400E-01
Normal-vs-Asian
8.433700E-02
Caucasian-vs-AfricanAmerican
1.850780E-01
Caucasian-vs-Asian
6.349400E-01
AfricanAmerican-vs-Asian
1.301600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.103240E-01
Normal-vs-Female
1.817150E-01
Male-vs-Female
1.988240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.694400E-02
Normal-vs-Age(41-60Yrs)
2.656600E-01
Normal-vs-Age(61-80Yrs)
1.137750E-01
Normal-vs-Age(81-100Yrs)
4.171700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.043000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.143800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.682800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.196020E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.418200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.684000E-02
Normal-vs-Daily Drinker
5.458400E-02
Normal-vs-Weekly Drinker
5.024000E-01
Normal-vs-Occasional Drinker
2.295000E-01
Normal-vs-Social Drinker
5.125900E-02
Non Drinker-vs-Daily Drinker
9.017400E-01
Non Drinker-vs-Weekly Drinker
5.684400E-02
Non Drinker-vs-Occasional Drinker
1.405820E-01
Non Drinker-vs-Social Drinker
1.716190E-01
Daily Drinker-vs-Weekly Drinker
8.621600E-02
Daily Drinker-vs-Occasional Drinker
1.731580E-01
Daily Drinker-vs-Social Drinker
2.027800E-01
Weekly Drinker-vs-Occasional Drinker
5.770200E-01
Weekly Drinker-vs-Social Drinker
4.453600E-01
Occasional Drinker-vs-Social Drinker
8.265800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.866400E-01
Normal-vs-Grade 2
9.710600E-01
Normal-vs-Grade 3
9.383200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.980400E-02
Grade 1-vs-Grade 3
2.707800E-01
Grade 1-vs-Grade 4
8.866400E-01
Grade 2-vs-Grade 3
3.061600E-01
Grade 2-vs-Grade 4
9.710600E-01
Grade 3-vs-Grade 4
9.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.159800E-02
Normal-vs-NonDiabetic
1.354200E-01
Diabetic-vs-NonDiabetic
1.324800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.626210E-01
Normal-vs-NoPancreatitis
1.194610E-01
Pancreatitis-vs-NoPancreatitis
5.092200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.041760E-01
Normal-vs-N1
1.710170E-01
N0-vs-N1
5.420400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.726000E-01
Normal-vs-TP53-NonMutant
1.811430E-01
TP53-Mutant-vs-TP53-NonMutant
5.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
